Summary
The effect of amphotericin B colloidal dispersion (ABCD) on selected immunological parameters and growth of the larval cysts in mice infected intraperitoneally with Echinococcus multilocularis protoscoleces was observed. ABCD was administered at a dose 10 mg/kg body weight twice a week from week 5 to 10 post infection (p.i.). The Echinococcus infection suppressed the proliferative response of splenic T lymphocytes to nonspecific mitogen concanavalin A throughout almost the whole course of the experiment and ABCD administration did not affect this inhibittion. The increase in the proliferative response of B lymphocytes to lipopolysaccharide was found in infected mice with ABCD treatment from week 6 to 10 p.i. ABCD induced a significant rise of the splenic CD4 T cell subpopulation in infected mice only on week 6 p.i. The CD8 T subpopulation was not influenced by the therapy. The level of serum Th1 cytokine IFN-γ in infected and ABCD treated mice was elevated only at week 8 p.i., while the level of serum Th2 cytokine IL-5 was not influenced by the therapy. The ABCD treatment inhibited the IFN-γ production by splenocytes in vitro from week 6 to 10 p.i. On the contrary, the IL-5 production in vitro was stimulated at weeks 8 and 12 p.i. None antiparasitic effect of ABCD on larval growth was determined.
Results suggest that amphotericin B colloidal dispersion did not affect the inhibited Th1 immune response after parasite infection. On the contrary, ABCD advanced the Th2 immune response development, which allows the progressive growth of the parasite.
Similar content being viewed by others
References
Abbas, A. K., Murphy, K. M., Sher, A. (1996): Functional diversity of helper T lymphocytes. Nature, 383: 787–793
Abu-Salah, K. M. (1996): Amphotericin B: an update. Brit. J. Biomed. Sci., 53: 122–133
Ammann, R. W., Eckert, J. (1996): Cestodes: Echinococcus. Gastroenter. Clin. North Am., 25: 655–689
Borošková, Z., Dvorožňáková, E., Ševčíková, Z. (2003): Cellular immune reactions of mice with alveolar echinococcosis after albendazole therapy. Helminthologia, 40: 187–194
Brajtburg, J., Bolard, J. (1996): Carrier effects on biological activity of amphotericin B. Clin. Microb. Rev., 9: 512–531
Brajtburg, J., Powderly, W. G., Kobayashi, G. S., Medoff, G. (1990): Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother., 34: 183–188
Bresson-Hadni, S., Liance, A., Meyer, J. P., Houin, R., Bresson, J. L., Vuitton, D. A. (1990): Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequental and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin. Exp. Immunol., 82: 378–383
Capece, B. P., Navarro, M., Arcalis, T., Castells, G., Toribio, L., Perez, F., Carretero, A., Ruberte, J., Arboix, M., Cristofol, C. (2003): Albendazole sulphoxide enantiomers in pregnant rats’ embryo concentrations and developmental toxicity. Vet. J., 165: 266–275
Christiansen, K. J., Bernard, E. M., Gold, J. W. M., Armstrong, D. (1985): Distribution and activity of amphotericin B in humans. J. Infect. Dis., 152: 1037–1043
Clements, J. S. Jr., Peacock, J. E. Jr. (1990): Amphotericin B revisited: reassessment of toxicity. Amer. J. Med., 88: 22–27
Clemons, K. V., Sobel, R. A., Williams, P. L., Stevens, D. A. (2001): Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits. Antimicrob. Agents Chemother., 45: 612–615
Dvorožňáková, E., Hrčková, G., Borošková, Z., Velebný, S., Dubinský, P. (2004): Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol. Int., 53: 315–325
Ehrenfreund-Kleinman, T., Domb, A. J., Jaffe, C. L., Nasereddin, A., Leshem, B., Golenser, J. (2005): The effect of amphotericin b derivatives on Leishmania and immune functions. J. Parasitol., 91: 158–163
Ellis, D. (2002): Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother., 49: 7–10
Emery, I., Liance, M., Deriaud, E., Vuitton, D. A., Houin, E., Leclerc, C. (1996): Characterization of T-cell immune responses of Echinococcus multilocularis-infected. Parasite. Immunol., 18: 463–472
Geginat, G., Kretschmar, M., Walter, S., Junker, D., Hof, H., Nichterlein, T. (1999): Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function. J. Infect. Dis., 180: 1186–1194
Gilbert, B. E., Wyde, P. R., Willson, S. Z. (1992): Aerosolized liposomal amphotericin B liposomes for treatment of pulmonary and systematic Cryptococcus neoformans infections in mice. Antimicrob. Agents Chemother., 36: 1466–1471
Gottstein, B., Haag, K., Walker, M., Matsumoto, J., Mejri, N., Hemphill, A. (2006): Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol. Int., 55: S45–S49
Hann, I. M., Prentice, H. G. (2001): Lipid-based amphotericin B: a review of the last 10 years of use. Int. J. Antimicrob. Agents, 17: 161–169
Heath, D. D. (1995): Immunology of Echinococcus infection. In Thompson, R. C. A., Lymbery, A. J. (Eds): Echinococcus and hydatid disease. CAB INTERNATIONAL, Wallingford, UK: 183–199
Hiemenz, J. W., Walsh, T. J. (1996): Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect. Dis., 22: S133–S144
Hrčková, G., Velebný, S. (1997): Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology, 114: 475–482
Inselmann, G., Volkmann A., Heidemann, H. T. (2000): Comparison of the effects of liposomal amphotericin B and conventional amphotericin B on propafenone metabolism and hepatic cztochrome P.450 in rats. Antimicrob. Agents Chemother., 44:131–133
Janknegt, R., DeMarie, S., Bakker-Woudenberg, I. A., Crommelin D. J. (1992): Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet., 23: 279–291
Joly, V., Farinotti, R., Saint-Julien, L., Chéron, M., Carbon, C., Zeni, P. (1994): In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with intralipid. Antimicrob. Agents Chemother., 38: 177–183
Karyotakis, N. C., Anaissie, E. J. (1994): Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice. Antimicrob. Agents Chemother., 38: 2660–2662
Kilwinski, J., Jenne, L., Jellen-Ritter, A., Radloff, P., Flick, W., Kern, P. (1999): T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine, 11: 373–381
Kizaki, T., Kobayashi, S., Ogasawara, K., Day, N. K., Good, R. A., Onoe, K. (1991): Immune suppression induced by protoscoleces of E. multilocularis in mice. Evidence for the presence of CD8dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J. Immunol., 147: 1659–1666
Manfras, B. J., Reuter, S., Wendland, T., Boehm, B. O., Kern, P. (2004): Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int. Immunol., 16: 43–50
Murray, H. W. (2005): Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. J. Immunol., 174: 4916–4923
Pagé, M., Bajaouni, N., Ciqo-Mars, B., Lemieux, P. (1988): Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol., 10: 785–793
Pérez-Serrano, J., Denegri, G., Casado, N., Rodríguez-Caabeiro, F. (1997): In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary Echinococcosis in mice. Int. J. Parasitol., 27: 1341–1345
Persat, F., Bouhours, J. F., Mojon, M., Petavy, A. F. (1990): Analysis of the monohexosylceramide fraction of Echinococcus multilocularis metacestodes. Mol. Biochem. Parasitol., 41: 1–6
Rama-Iniguez, S., Dea-Ayuela, M. A., Sanchez-Brunete J. A., Torrado, J. J., Alunda, J. M., Bolas-Fernandez, F. (2006): Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation. Antimicrob. Agents Chemother., 50: 1195–1201
Resch, K. (1999): Cytokines. In Nijkamp F. P., Parnham, M. J. (Eds): Principles of Immunopharmacology. Birghäuser Verlag, Basel, Boston, Berlin: 53–81
Reuben, J. M, Tanner, C. E. (1983): Protection against experimental echinococcosis by non-specifically stimulated peritoneal cells. Parasite Immunol., 5: 61–66
Reuter, S., Jensen, B., Buttenschoen, K., Kratzer, W., Kern, P. (2000): Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother., 46: 451–456
Reuter, S., Merkle, M., Brehm, K., Kern, P., Manfras, B. (2003a): Effect of amphotericin B on larval growth of Echinococcus multilocularis. Antimicrob. Agents Chemother., 47: 620–625
Reuter, S., Buck, A., Grebe, O., Nussle-Kugele, K., Kern, P., Manfras, B. J. (2003b): Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob. Agents Chemother., 47: 3586–3591
Rigano, R., Profumo, E., Buttari, B., Teggi, A., Siracusano, A. (1999): Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis. Clin. Exp. Immunol., 118: 95–101
Sau, K., Mambula, S. S., Latz, E., Henneke, P., Golenbock, D. T., Levitz, S. M. (2003): The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor-and CD14-dependent mechanism. J. Biol. Chem., 278: 37561–37568
Schantz, P. M. (2002): Progress and challenges in biology, treatment and control of echinococcosis. Abstracts ICOPA X, Vancouver, Canada: 243
Schindler, J. J., Warren, R. P., Allen, S. D., Jackson, M. K. (1993): Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and compromised mice. Antimicrob. Agents Chemother, 37: 2716–2721
Simitsopoulou, M., Roilides, E., Dotis, J., Dalakiouridou, M., Dudkova, A. F., Andreadou, E., Walsh, T. J. (2005): Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob. Agents Chemother., 49: 1397–1403
Stein, S. H., Little, J. R., Little, K. D. (1987): Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains. Cell. Immunol., 105: 99–109
Sturm, D., Menzel, J., Gottstein, B., Kern, P. (1995): Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect. Immun., 63: 1688–1697
Šoltýs, J., Quinn, M. T. (1999): Modulation of endotoxin-and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect. Immun., 67: 244–252
Šoltýs, J., Turčeková, L.’, Rycke, de P. H. (1999): The effect Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia, 36: 25–30
Thompson, R. C. A. (1995): Biology and systematics of Echinococcus. In Thompson, R. C. A., Lymbery, A. J. (Eds): Echinococcus and hydatid disease. CAB INTERNATIONAL, Wallingford, UK: 1–50
Vuitton, D. A. (2003): The ambiguous role of immunity in Echinococcosis: protection of the host or of the parasite? Acta. Trop., 85: 119–132
Vuitton, D. A., Zhang, S. L., Yang, Y., Godot, V., Beurton, I., Mantion, G., Bresson-Hadni, S. (2006): Survival strategy of Echinococcus multilocularis in the human host. Parasitol. Int., 55: S51–S55
Vuitton, D. A. (1999): New trends in the treatment of echinococcosis. Helminthologia, 36: 167–170
Wolf, J. E., Massof, S. E. (1990): In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect. Immun., 58:1296–1300
Yardley, V., Croft, S. L. (1999): In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections. Am. J. Trop. Med. Hyg., 61: 193–197
Zhang, Z., Lipman, J. M., Diener, R. M., Thomas, P. (2006): Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC). Int. J. Toxicol., 25: 487–492
Author information
Authors and Affiliations
About this article
Cite this article
Porubcová, J., Dvorožňáková, E. & Ševčíková, Z. Immune response of mice to Echinococcus multilocularis infection after therapy with amphotericin B colloidal dispersion. Helminthologia 44, 47–56 (2007). https://doi.org/10.2478/s11687-007-0003-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.2478/s11687-007-0003-y